Blood and Immunity Flashcards
Explain the threat posed by the many different types of infectious agents, and the requirements of an effective immune system.
Describe the main features of the systemic immune system, the lymphoid system and lymphocyte recirculation.
infectious agents can release toxins and damage cells.
an effective immunne systme contains neutrophils, eosinophils, basophils, mast cells, macrophages and monocytes, natural killer cells, dendrite cells, Th and Tc cells and B cells.
List and categorise the main cellular and secreted mediators of immunity.
Antimicrobial secretions are antibodies/immunoglobulins, pentraxins, collections, complement proteins, defensins, lytic enzymes, interferons and cytotoxins.
Regulatory or inflammatory secretions are cytokines, chemokines, prostaglandins, leukotrienes and histamines. The main division are ones that have direct protective effects in the immune response, and others have roles in regulating the immune responses.
Explain the requirements for recognition and defensive functions within the immune system.
The body needs to have mechanisms for recognising infections, with interaction with microbes and their counterparts, and defence, which is the elimination of microbes and their products.
List the main properties of innate and adaptive immunity.
innate immunity - rapidly activated, same on repeat exposure, moderate efficacy, general response, recognition of ‘pathogen-associated molecular patterns’ (PAMPs) and recognition by ‘pattern recognition receptors’ (PRRs), activity of neutrophils, eosinophils, basophils, mast cells, monocytes and macrophages, dendritic cells and natural killer cells
adaptive immunity - slow, improves with repeated exposure, high efficacy, specific response, recognises antigens, ecognises this by antigen-specific receptors clonally expressed by lymphocytes, T and B cells
Outline the stages of primary and secondary immune responses, indicating the contributions of innate and adaptive components.
primary - innate response occurs at site of infection, complement proteins and macrophages introduced, inflammatory response, inflammatory mediators are produced from either complement proteins, macrophages or mast cells, attract leukocytes and serum proteins from the bloodstream
Components of infective microbes (antigens) are carried to a draining lymph node. Some are captured by dendritic cells and carried to the lymphoid tissue. Specific T and B lymphocytes are produced and recirculated to the site of infection.
Following primary infection, memory T and B cells give faster and bigger responses on a second exposure to the same infection.
Outline the different strategies of immunity required to combat different categories of infective agents.
For an extracellular infection, complement proteins, phagocytes and antibodies are involved as they can bind to the surface of the microbe.
For an intracellular vesicular infection, where the microbe has been engulfed by a macrophage, helper T cells hyperactivate the macrophage to digestive resistant microbes.
For intracellular cytosolic infections, interferon proteins, natural killer cells and cytotoxic T cells are activated. This applies in particular to viruses. Interferons block the ability of viruses to replicate in cells. Natural killer cells and cytotoxic T cells kill infected cells to limit virus reproduction.
Give examples of immunopathological disorders, including immunodeficiency, allergy, autoimmunity, transplant rejection and lymphoproliferative disorders.
immunodeficiency - primary SCIDS, secondary AIDS
allergy - allergic rhinitis (hayfever)
autoimmunity - autoimmune thyroiditis and rheumatoid arthritis.
transplant rejection - kidney
lymphoproliferative disorders - lymphoma, leukemia, myelomas
Describe the range of secreted and cell surface pattern recognition receptors of the innate immune system, including Creactive protein, mannan binding lectin, CD14, mannose receptor, scavenger receptor, and Tolllike receptors.
macrophages can express a range of pattern recongition receptors for various microbes: mannose receptor, glucan receptor, scavenger receptor, CD11b/CD18, LPS receptor (CD14)
Toll-like receptors (TLRs) recognise a variety of pathogen-associated molecular patterns (PAMPs). There are a variety of different TRLs present in humans. Some are present on the surface of the cell which they interact with. Others are found in the cytoplasm of the cells and interact with the nucleic acids of the microbes that have invaded the cell.
Explain the features of specific antigen recognition by antibodies.
Antibodies are also known as immunoglobulin. They include antigen combining sites, which the antigenic determinant, or epitope, joins to.
The epitope and combining site are held together by noncovalent interactions between their surfaces. These are only effective over short distances.
The combining site has to be complementary to the shape of the epitope.
Describe the direct recognition of native antigens by surface immunoglobulins of B lymphocytes, leading to plasma cell formation and antibody production.
When an epitope binds to a surface immunoglobulin, this triggers the activation of the B cell. The B cell then differentiates into a plasma cell.
The plasma cell no longer expresses surface immunoglobulins. Instead, its activity is focused on creating antibodies.
Explain clonal selection of antigen specific lymphocytes, and how this ensures the specificity of the adaptive immune response.
Clonal selection occurs by specific lymphocytes being produced due to their antigen recognition. The lymphocytes with the highest affinity will be reproduced.
Explain how clonal selection and memory cell formation are utilised in vaccination.
The injection of an inactivated form of a virus can lead to a small amount of antibody production. Then, on infection of an activated form of the virus, a much larger antibody response is generated.
Describe the structure of immunoglobulins.
The immunoglobulin has a Y-shaped structure. It is made of four polypeptide chains: two logn heavy chains and two short light chains. The antigen combining sites are formed by the terminal regions of the heavy and light chains.
The light chains have two domains, and the heavy chains have four domains. Each domain is stabilised by a disulfide bond. The disulfide bonds bind covalently to each other, connecting the two heavy chain strands and connecting the light chain to the heavy chain.
Outline the molecular features of immunoglobulin class switching and how this determines the quality of the antibody response.
Class switching can change the gene expressed and the constant domain of the heavy chain.
Describe the structure and tissue distribution of the immunoglobulin classes.
IgM (pentamers) - blood
IgG (monomers) - blood, tissues, placental transfer
IgA - blood/tissues (monomers), mucosal secretions and milk (dimers)
IgE (monomers) - tissues (bound to mast cells)
IgD - mucosa of upper aerodigestive tract
Outline the role of antimicrobial defensins.
Their most common antimicrobial function is the formation of destructive pores in membranes of pathogens including enveloped viruses.
Explain how particular isotypes of antibodies interact with defence components by virtue of the properties of their Fc regions.
Antibodies can also act as intermediaries to activate other defensive components that interact with the Fc regions of antibodies. Thus, IgM and IgG antibodies can activate the complement system of proteins; phagocytes have Fc receptors (FcR) that bind IgG or IgA; natural killer cells similarly bind IgG; mast cells have FcR specific for IgE; eosinophils have FcR specific for IgG or IgE.
Outline the properties of complement and the pathways of complement activation.
A complement is a collection of proteins found in the circulation and tissues fluids. They complement the effects of antibodies. Complement proteins can act as activation enzymes, immune defence molecules, and control proteins.
The activation of complement proteins is triggered by infection and immune activation, and occurs as a cascade or chain reaction with amplification. The central event of complement activation is the conversion of C3 to C3a and C3b. These are known as C3 convertase enzymes.
Describe the structure of the membrane attack complex of complement.
Membrane attack complex of complement refers to the association of the complement proteins C5, C6, C7, C8, and C9 to form a potentially cytolytic complex. When C5 is activated in either the classical or alternative pathway, the resulting C5b molecule contains binding sites for the next components in the pathway.
Describe the innate and adaptive mechanisms of opsonization of microbes for phagocytosis.
Another way for phagocytosis to occur is by coating the microbes with other molecules of the immune system to make the bacteria more attractive to be bound by the phagocyte. The chemicals used to do theis are known as opsonins. Pattern recognition molecules are a form of opsonin.
Outline the mechanisms of phagocytosis and intracellular killing.
The macrophage expresses receptors for many bacterial constituents. Bacteria binding to macrophage receptors initiate the release of cytokines and small lipid mediators of inflammation. The macrophage then engulfs and digests the bacteria to which they bind.
Outline the extracellular killing of large parasitic organisms by eosinophils.
Phagocytes contain lysosomes and phagolysosomes to digest engulfed microbes. Some microbes are too large to be engulfed, an eosinophil can be bound to the surface of the parasite via complement and C receptors. It releases digestive enzymes onto the outside of the parasite. This is extracellular digestion.
Explain how mast cells can be triggered to release inflammatory mediators.
Mast cells are similar to basophils, but unlike them are resident in tissues. Mass cells are covered in specific IgE antibodies, if an antigen binds, this triggers the activation of the mass cell. C3a and C5a can also bind to the mast cells and trigger activation. Mast cell degranulation is where mast cells release their granules, which are inflammatory mediators.
Describe the stages of the inflammatory process, and give examples of the main inflammatory mediators.
The purpose of inflammation is to promote the movement of cells and molecules of the immune system from the blood to the tissues and cells where the infection is located. Introducers of inflammation are C3a and C5a which are known as anaphylatoxins.
Many inflammatory mediators are present on the walls of blood vessels. They can cause vasodilation, leukocytes are not moving slower through the infected tissue.
Outline the stages of leukocyte endothelial interaction and leukocyte extravasation, and the main adhesion molecules involved in these processes.
Adhesion molecules (eg selectins and itegrins) are expressed for leukocytes to bind to. Vascular permeability increases, facilitating the movement of leukocytes stuck to the blood vessel wall into the infected tissue, and more fluid moves to the infected area, bringing complement proteins and antibodies.